Chemoinformaics analysis of Amaranthin
Molecular Weight | 726.597 | nRot | 10 |
Heavy Atom Molecular Weight | 692.325 | nRig | 34 |
Exact Molecular Weight | 726.176 | nRing | 5 |
Solubility: LogS | 0.141 | nHRing | 4 |
Solubility: LogP | -3.562 | No. of Aliphatic Rings | 4 |
Acid Count | 4 | No. of Aromatic Rings | 1 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 85 | No. of Aliphatic Hetero Cycles | 4 |
No. of Heavy Atom | 51 | No. of Aromatic Carbocycles | 1 |
nHetero | 21 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 30 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
No. of Oxygen atom | 19 | No. of Arom Bond | 6 |
nHA | 17 | APOL | 90.209 |
nHD | 11 | BPOL | 47.673 |
QED | 0.101 |
Synth | 6.003 |
Natural Product Likeliness | 1.855 |
NR-PPAR-gamma | 0.028 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.989 |
HIA | 0.998 |
CACO-2 | -7.048 |
MDCK | 0.000312286 |
BBB | 0.268 |
PPB | 0.21484 |
VDSS | 0.533 |
FU | 0.576105 |
CYP1A2-inh | 0.001 |
CYP1A2-sub | 0.001 |
CYP2c19-inh | 0.003 |
CYP2c19-sub | 0.025 |
CYP2c9-inh | 0.003 |
CYP2c9-sub | 0.066 |
CYP2d6-inh | 0.001 |
CYP2d6-sub | 0.05 |
CYP3a4-inh | 0.007 |
CYP3a4-sub | 0 |
CL | 1.303 |
T12 | 0.833 |
hERG | 0.005 |
Ames | 0.006 |
ROA | 0.12 |
SkinSen | 0.768 |
Carcinogencity | 0.049 |
EI | 0.004 |
Respiratory | 0.683 |
NR-Aromatase | 0.01 |
Antiviral | Yes |
Prediction | 0.657988 |